US 9745576
RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
granted A61PA61P21/00A61P21/02
Quick answer
US patent 9745576 (RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN TECHNOLOGIES B.V.
- Grant date
- Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P21/00, A61P21/02, A61P25/00, A61P25/14